Figure 1
Figure 1. Relation between age group and percentage of patients experiencing bleeding of various grades, in all patients and stratified by disease treatment category. Age group comparisons with pairwise P values < .05 are noted (A: 0-5 years vs 6-12 years; B: 0-5 years vs 13-18 years; C: 0-5 years vs ≥ 19 years; D: 6-12 years vs 13-18 years; E: 6-12 years vs ≥ 19 years; F: 13-18 years vs ≥ 19 years). (A) At least 1 day with grade 2 or higher bleeding (overall test for age group, P < .001; interaction of age group with disease treatment category, P = .04), (B) ≥ 1 day with grade 3 or higher bleeding (overall test for age group, P = .02; P for interaction = .13), (C) ≥ 1 day with grade 4 bleeding (P = .12, P for interaction not estimable).

Relation between age group and percentage of patients experiencing bleeding of various grades, in all patients and stratified by disease treatment category. Age group comparisons with pairwise P values < .05 are noted (A: 0-5 years vs 6-12 years; B: 0-5 years vs 13-18 years; C: 0-5 years vs ≥ 19 years; D: 6-12 years vs 13-18 years; E: 6-12 years vs ≥ 19 years; F: 13-18 years vs ≥ 19 years). (A) At least 1 day with grade 2 or higher bleeding (overall test for age group, P < .001; interaction of age group with disease treatment category, P = .04), (B) ≥ 1 day with grade 3 or higher bleeding (overall test for age group, P = .02; P for interaction = .13), (C) ≥ 1 day with grade 4 bleeding (P = .12, P for interaction not estimable).

Close Modal

or Create an Account

Close Modal
Close Modal